HIZENTRA DM
Live / Allowed — Second extension granted (statement of use) (as of 29 Apr 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 06 Sept 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98736641
- Mark type
- Word mark
- Filed
- 06 Sept 2024
- Published for opposition
- 08 Apr 2025
- Attorney of record
- Scott D. Woldow
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of immuno deficiency disorders; intravenous immunoglobulins for use in the treatment of immuno deficiency disorders and in immune replacement therapy; Pharmaceutical preparations for the treatment of dermatomyositis, inflammatory diseases and inflammatory conditions, muscle conditions and skin conditions; pharmaceutical preparations for the treatment of skin rash, weight loss, fever, lung conditions, light sensitivity, calcium deposits, and cardiovascular conditions; pharmaceutical preparations for the treatment of inflammatory myopathy and muscular conditions
Owner
- CSL Behring AG, Bern 22, CH
- CSL Behring AG, Bern 22, CH
Prior registrations
Prosecution history
- 29 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Apr 2026 — SOU EXTENSION 2 GRANTED
- 29 Apr 2026 — SOU EXTENSION 2 FILED
- 29 Apr 2026 — SOU TEAS EXTENSION RECEIVED
- 03 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Nov 2025 — SOU EXTENSION 1 GRANTED
- 03 Nov 2025 — SOU EXTENSION 1 FILED
- 03 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Apr 2025 — PUBLISHED FOR OPPOSITION
- 02 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Mar 2025 — EXAMINER'S AMENDMENT ENTERED
- 13 Mar 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED